Microvesicular steatosis and steatohepatitis: Role of mitochondrial dysfunction and lipid peroxidation

Journal of Hepatology, Supplement

Volumn 26, Issue 1, 1997, Pages 13-22

  Fromenty, Bernard ^a   Berson, Alain ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; MITOCHONDRIAL DNA;

ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DNA REPLICATION; FATTY LIVER; FEMALE; GENETICS; HUMAN; LIPID PEROXIDATION; LIVER MITOCHONDRION; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ANIMALS; DNA REPLICATION; DNA, MITOCHONDRIAL; FATTY LIVER; FEMALE; HUMANS; LIPID PEROXIDATION; MITOCHONDRIA, LIVER; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0030630208     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(97)82328-8     Document Type: Article

References (54)

1. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995; 67: 101-54.
2. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol 1995; 23 (suppl. 1): 16-24.
3. Berson A, Renault S, Lettéron P, Robin MA, Fromenty B, Fau D, Le Bot MA, Riché C, Durand-Shneider AM, Feldmann G, Pessayre D. Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction. Gastroenterology 1996; 110: 1878-90.
4. Berson A, Schmets L, Fau D, Wolf C, Fromenty B, Deschamps D, Pessayre D. Inhibition by nilutamide of the mitochondrial respiratory chain and ATP formation. Possible contribution to the adverse effects of this antiandrogen. J Pharmacol Exp Ther 1994: 270: 167-76.
5. Fau D, Eugène D, Berson A, Lettéron P, Fromenty B, Fisch C, Pessayre D. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J Pharmacol Exp Ther 1994; 269: 954-62.
6. Berson A, Wolf C, Berger V, Fau D, Chachaty C, Fromenty B, Pessayre D. Generation of free radicals during the reductive metabolism of the nitroaromatic compound, nilutamide. J Pharmacol Exp Ther 1991; 257: 714-9.
7. Fau D, Berson A, Eugène D, Fromenty B, Fisch C, Pessayre D. Mechanism for the hepatotoxicity of the anti-androgen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes. J Pharmacol Exp Ther 1992; 263: 69-77.
8. Berson A, Wolf C, Chachaty C, Fisch C, Fau D, Eugène D, Loeper J, Gauthier JC, Beaune PH, Pompon D, Maurel P, Pessayre D. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies. J Pharmacol Exp Ther 1993; 265: 366-72.
9. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatotis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol (in press).
10. Farrell G. Drug-induced Liver Disease. London: Churchill-Livingstone, 1994.
11. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1992, 61: 1175-212.
12. Schon EA, Hirano M, DiMauro S. Mitochondrial encephalomyopathies: Clinical and molecular analysis. J Bioenerg Biomembr 1994; 26: 291-9.
13. Watmough NJ, Bindoff LA, Birch-Machin MA, Jackson S, Bartlett K, Ragan CI, Poulton J, Gardiner RM, Sherratt HSA, Turnbull DM. Impaired mitochondrial β-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest 1990; 85: 177-84.
14. Hale DE, Bennett MJ. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr 1992, 121: 1-11.
15. Fromenty B, Manfredi G, Sadlock J, Zhang L, King MP, Schon EA. Efficient and specific amplification of identified partial duplications of human mitochondrial DNA by long PCR. Biochim Biophys Acta 1996; 1308: 222-30.
16. Bioulac-Sage P, Parrot-Roulaud, Mazat JP, Lamireau T, Coquet M, Sandler B, Demarquez JL, Cormier V, Munnich A, Carré M, Balabaud C. Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liver. Hepatology 1993; 18: 839-46.
17. Grimbert S, Fromenty B, Fisch C, Lettéron P, Berson A, Durand-Schneider AM, Feldmann G, Pessayre, D. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy. Hepatology 1993; 17: 628-37.
18. Grimbert S, Fisch C, Deschamps D, Berson A, Fromenty B, Feldmann G, Pessayre D. Effects of female sex hormones on liver mitochondria in non-pregnant female mice: possible role in acute fatty liver of pregnancy. Am J Physiol 1995; 268: G107-15.
19. Mansouri A, Fromenty B, Durand F, Degott C, Bernuau J, Pessayre D. Assessment of the prevalence of genetic metabolic defects in acute fatty liver of pregnancy. J Hepatol 1996; 25: 781.
20. Heubi JE, Partin JC, Partin JS, Schubert WK. Reye's syndrome: current concepts. Hepatology 1987; 7: 155-64.
21. Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D. Inhibition by salicylic acid of the activation and thus oxidation of long-chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259: 894-904.
22. Fréneaux E, Fromenty B, Berson A, Labbe G, Degott C, Lettéron P, Larrey D, Pessayre D. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharmacol Exp Ther 1990; 255: 529-35.
23. Fromenty B, Lettéron P, Fisch C, Berson A, Deschamps D, Pessayre D. Evaluation of human blood lymphocytes as a model to study the effects of drugs on human mitochondria. Effects of low concentrations of amiodarone on fatty acid oxidation, ATP levels and cell survival. Biochem Pharmacol 1993; 46: 421-32.
24. Genève J, Hayat-Bonan B, Labbe G, Degott C, Lettéron P, Fréneaux E, Le Dinh T, Larrey D, Pessayre D. Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug. J Pharmacol Exp Ther 1987; 242: 1133-7.
25. Rifflet H, Vuillemin E, Rifflet I, Oberti F, Pilette C, Cales P. Atteinte hépatique aiguë douloureuse et fébrile associée à la prise de tianeptine. Gastroenterol Clin Biol 1996; 20: 606-7.
26. Balleyguier C, Stérin D, Ziol M, Trinchet JC. Hépatite mixte aiguë à la tianeptine. Gastroenterol Clin Biol 1996; 20: 607-8.
27. Le Dinh T, Fréneaux E, Labbe G, Lettéron P, Degott C, Genève J, Berson A, Larrey D, Pessayre D. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1988; 247: 745-50.
28. Fromenty B, Fréneaux E, Labbe G, Deschamps D, Larrey D, Lettéron P, Pessayre, D. Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice. Biochem Pharmacol 1989; 38: 3743-51.
29. Fréneaux E, Labbe G, Lettéron P, Le Dinh T, Degott C, Genève J, Larrey D, Pessayre, D. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 1988; 8: 1056-62.
30. Labbe G, Fromenty B, Fréneaux E, Morzelle V, Lettéron P, Berson A, Pessayre, D. Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 1991; 41: 638-41.
31. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nature Med 1995; 1: 417-22.
32. Mitsuya H, Jarrett RF, Matsukura M, Veronese FDM, De Vico AL, Sarngadharan MG, Johns DG, Reitz MS, Broder S. Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2′,3′-dideoxynucleosides in vitro. Proc Natl Acad Sci USA 1987; 84: 2033-7.
33. Simpson MV, Chin CD, Keilbaugh SA, Lin TS, Prusoff WH. Studies on the inhibition of mitochondrial DNA replication by 3′-azido-3′-deoxythymidine and other dideoxynucleoside analogs which inhibits HIV-1 replication. Biochem Pharmacol 1989; 38: 1033-6.
34. Lai KK, Gang DL, Zawacki JK, Cooley TP. Fulminant hepatic failure associated with 2′,3′-dideoxyinosine (ddI). Ann Intern Med 1991; 115:283-4.
35. McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. New Engl J Med 1995; 33: 1099-105.
36. Richardson FC, Engelhardt JA, Bowsher RR. Fialuridine accumulates in DNA of dogs, monkeys and rats following long-term oral administration. Proc Natl Acad Sci USA 1994; 91: 12003-7.
37. Lewis W, Levine ES, Griniuviene B, Tankersley KO, Colacino JM, Sommadossi JP, Watanabe KA, Perrino FW. Fialuridine and its metabolites inhibit DNA polymerase γ at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proc Natl Acad Sci USA 1996; 93: 3592-7.
38. Shan B, Vazquez E, Lewis JA. Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon-mediated responses. EMBO J 1990; 9: 4307-14.
39. Lewis JA, Huq A, Najarro P. Inhibition of mitochondrial function by interferon. J Biol Chem 1996; 22: 13184-90.
40. Ames BN, Shigenaga MK, Hagen TM. Mitochondrial decay in aging. Biochim Biophys Acta 1995; 1271: 165-70.
41. Nordmann R, Ribière C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Rad Biol Med 1992; 12: 219-10.
42. Kukielka E, Dicker E, Cederbaum AI. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 1994; 309: 377-86.
43. Fromenty B, Grimbert S, Mansouri A, Beaugrand M, Erlinger S, Rötig A, Pessayre D. Hepatic mitochondrial DNA deletion in alcoholics. Association with microvesicular steatosis. Gastroenterology 1995; 108: 193-200.
44. Lettéron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis leads to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 200-8.
45. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
46. Zatloukal K, Böck G, Rainer I, Denk H, Weber H. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Lab Invest 1991; 64: 200-6.
47. Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 1990; 42: 327-54.
48. Guigui B, Perrot S, Berry JP, Fleury-Feith J, Martin N, Métreau JM, Dhumeaux D, Zafrani ES. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 1988; 8: 1063-8.
49. Fromenty B, Fisch C, Labbe G, Degott C, Deschamps D, Berson A, Lettéron P, Pessayre D. Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1990; 255: 1371-6.
50. Fromenty B, Fisch C, Berson A, Lettéron P, Larrey D, Pessayre, D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 1990; 255: 1377-84.
51. Deschamps D, De Beco V, Fisch C, Fromenty B., Guillouzo A, Pessayre D. Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology 1994; 19: 948-61.
52. Lettéron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Degott C, Benhamou JP, Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol abusers. Gut 1993; 34: 409-14.
53. Krähenbühl S, Talos C, Reichen J. Mechanisms of impaired hepatic fatty acid metabolism in rats with long-term bile duct ligation. Hepatology 1994; 19: 1272-81.
54. Sokol RJ, Devereaux M, Khandwala R, O'Brien K. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes. Hepatology 1993; 17: 869-81.